Publications for Markus Hofer 2016

advertisement
Publications for Markus Hofer
Publications for Markus Hofer
2016
Mikaelyan, A., Thompson, C., Hofer, M., Brune,
A. (2016). Deterministic Assembly of Complex
Bacterial Communities in Guts of Germ-Free
Cockroaches. Applied and Environmental
Microbiology, 82(4), 1256-1263. <a
href="http://dx.doi.org/10.1128/AEM.03700-15"
>[More Information]</a>
Hofer, M., Campbell, I. (2016).
Immunoinflammatory diseases of the central
nervous system - The tale of two cytokines.
British Journal of Pharmacology, 173(4),
716-728. <a
href="http://dx.doi.org/10.1111/bph.13175">[Mo
re Information]</a>
Suprunenko, T., Hofer, M. (2016). The emerging
role of interferon regulatory factor 9 in the
antiviral host response and beyond. Cytokine &
Growth Factor Reviews, 29, 35-43.
2015
Almolda, B., de Labra, C., Barrera, I., Gruart, A.,
Delgado-Garcia, J., Villacampa, N., Vilella, A.,
Hofer, M., Hidalgo, J., Campbell, I., et al (2015).
Alterations in microglial phenotype and
hippocampal neuronal function in transgenic
mice with astrocyte-targeted production of
interleukin-10. Brain, Behavior, and Immunity,
45, 80-97. <a
href="http://dx.doi.org/10.1016/j.bbi.2014.10.01
5">[More Information]</a>
Campbell, L., Simonin, A., Chen, C., Ferdous, J.,
Padula, M., Harry, E., Hofer, M., Campbell, I.,
Carter, D. (2015). Cryptococcus Strains with
Different Pathogenic Potentials Have Diverse
Protein Secretomes. Eukaryotic Cell (Online),
14(6), 554-563. <a
href="http://dx.doi.org/10.1128/EC.00052-15">[
More Information]</a>
Visekruna, A., Linnerz, T., Martinic, V.,
Vachharajani, N., Hartmann, S., Harb, H., Joeris,
T., Pfefferle, P., Hofer, M., Steinhoff, U. (2015).
Transcription factor c-Rel plays a crucial role in
driving anti-CD40-mediated innate colitis.
Mucosal Immunology, 8(2), 307-315. <a
href="http://dx.doi.org/10.1038/mi.2014.68">[M
ore Information]</a>
2014
Teymoortash, A., Zieger, L., Hoch, S.,
Pagenstecher, A., Hofer, M. (2014). Distinct
microscopic features of perineural invasion in
adenoid cystic carcinoma of the head and neck.
Histopathology, 64(7), 1037-1039. <a
href="http://dx.doi.org/10.1111/his.12210">[Mor
e Information]</a>
Li, W., Hofer, M., Jung, S., Lim, S., Campbell, I.
(2014). IRF7-Dependent Type I Interferon
Production Induces Lethal Immune-Mediated
Disease in STAT1 Knockout Mice Infected with
Lymphocytic Choriomeningitis Virus. Journal of
Virology, 88(13), 7578-7588. <a
href="http://dx.doi.org/10.1128/JVI.03117-13">[
More Information]</a>
Nocon, A., Ip, J., Terry, R., Lim, S., Getts, D.,
Muller, M., Hofer, M., King, N., Campbell, I.
(2014). The Bacteriostatic Protein Lipocalin 2 Is
Induced in the Central Nervous System of Mice
with West Nile Virus Encephalitis. Journal of
Virology, 88(1), 679-689. <a
href="http://dx.doi.org/10.1128/JVI.02094-13">[
More Information]</a>
2013
Zimmermann, J., Krauthausen, M., Hofer, M.,
Heneka, M., Campbell, I., Muller, M. (2013).
CNS-Targeted Production of IL-17A Induces
Glial Activation, Microvascular Pathology and
Enhances the Neuroinflammatory Response to
Systemic Endotoxemia. PloS One, 8(2), 1-13. <a
href="http://dx.doi.org/10.1371/journal.pone.005
7307">[More Information]</a>
Siegfried, A., Berchtold, S., Manncke, B.,
Deuschle, E., Reber, J., Ott, T., Weber, M.,
Kalinke, U., Hofer, M., Hatesuer, B., et al
(2013). IFIT2 is an effector protein of type I
IFN-mediated amplification of
lipopolysaccharide (LPS)-induced TNF-α
secretion and LPS-induced endotoxin shock. The
Journal of Immunology, 191(7), 3913-3921. <a
href="http://dx.doi.org/10.4049/jimmunol.12033
05">[More Information]</a>
Li, W., Hofer, M., Nocon, A., Manders, P.,
Campbell, I. (2013). Interferon regulatory factor
7 (IRF7) is required for the optimal initial control
but not subsequent clearance of lymphocytic
choriomeningitis virus infection in mice.
Virology, 439(2), 152-162. <a
href="http://dx.doi.org/10.1016/j.virol.2013.02.0
15">[More Information]</a>
Hofer, M., Campbell, I. (2013). Type I interferon
in neurological disease-The devil from within.
Cytokine and Growth Factor Reviews, 24(3),
257-267. <a
href="http://dx.doi.org/10.1016/j.cytogfr.2013.03
.006">[More Information]</a>
2012
Hofer, M., Riehmer, V., Kuhnt, D., Braun, V.,
Nimsky, C., Weber, R., Sommer, C.,
Pagenstecher, A. (2012). Genomic profiling to
assess the clonal relationship between
histologically distinct intracranial tumours.
Neuropathology and Applied Neurobiology,
38(5), 500-504. <a
Publications for Markus Hofer
href="http://dx.doi.org/10.1111/j.1365-2990.201
2.01280.x">[More Information]</a>
Hofer, M., Li, W., Manders, P., Terry, R., Lim,
S., King, N., Campbell, I. (2012). Mice deficient
in STAT1 but not STAT2 or IRF9 develop a
lethal CD4+ T-cell-mediated disease following
infection with lymphocytic choriomeningitis
virus. Journal of Virology, 86(12), 6932-6946.
<a
href="http://dx.doi.org/10.1128/JVI.07147-11">[
More Information]</a>
Getts, D., Terry, R., Getts, M., Muller, M., Rana,
S., Deffrasnes, C., Ashhurst, T., Radford, J.,
Hofer, M., Thomas, S., Campbell, I., King, N.
(2012). Targeted blockade in lethal West Nile
virus encephalitis indicates a crucial role for very
late antigen (VLA)-4-dependent recruitment of
nitric oxide-producing macrophages. Journal of
Neuroinflammation, 9(1), 1-8. <a
href="http://dx.doi.org/10.1186/1742-2094-9-24
6">[More Information]</a>
2011
Ip, J., Nocon, A., Hofer, M., Lim, S., Müller, M.,
Campbell, I. (2011). Lipocalin 2 in the central
nervous system host response to systemic
lipopolysaccharide administration. Journal of
Neuroinflammation, 8(124), 1-15. <a
href="http://dx.doi.org/10.1186/1742-2094-8-12
4">[More Information]</a>
2010
Thompson, C., Hofer, M., Campbell, I., Holmes,
A. (2010). Community Dynamics in the Mouse
Gut Microbiota: A Possible Role for
IRF9-Regulated Genes in Community
Homeostasis. PloS One, 5(4),
e10335-1-e10335-9. <a
href="http://dx.doi.org/10.1371/journal.pone.001
0335">[More Information]</a>
Muller, M., Carter, S., Hofer, M., Campbell, I.
(2010). Review: The chemokine receptor
CXCR3 and its ligands CXCL9, CXCL10 and
CXCL11 in neuroimmunity - a tale of conflict
and conundrum. Neuropathology and Applied
Neurobiology, 36(5), 368-387. <a
href="http://dx.doi.org/10.1111/j.1365-2990.201
0.01089.x">[More Information]</a>
Ellis, S., Gysbers, V., Manders, P., Li, W.,
Hofer, M., Muller, M., Campbell, I. (2010). The
Cell-Specific Induction of CXC Chemokine
Ligand 9 Mediated by IFN-gamma in Microglia
of the Central Nervous System Is Determined by
the Myeloid Transcription Factor PU.1. The
Journal of Immunology, 185(3), 1864-1877. <a
href="http://dx.doi.org/10.4049/jimmunol.10009
00">[More Information]</a>
Hofer, M., Li, W., Lim, S., Campbell, I. (2010).
The type I interferon-alpha mediates a more
severe neurological disease in the absence of the
canonical signaling molecule interferon
regulatory factor 9. The Journal of Neuroscience,
30(3), 1149-1157. <a
href="http://dx.doi.org/10.1523/JNEUROSCI.37
11-09.2010">[More Information]</a>
Campbell, I., Hofer, M., Pagenstecher, A.
(2010). Transgenic models for cytokine-induced
neurological disease. Biochimica et Biophysica
Acta-Molecular Basis of Disease, 1802 (10),
903-917. <a
href="http://dx.doi.org/10.1016/j.bbadis.2009.10.
004">[More Information]</a>
2009
Vetter, M., Hofer, M., Roth, E., Pircher, H.,
Pagenstecher, A. (2009). Intracerebral
interleukin 12 induces glioma rejection in the
brain predominantly by CD8+ T cells and
independently of interferon-gamma. Journal of
Neuropathology and Experimental Neurology,
68(5), 525-534. <a
href="http://dx.doi.org/10.1097/NEN.0b013e318
1a2afa0">[More Information]</a>
Quintana, A., Muller, M., Frausto, R., Ramos,
R., Getts, D., Sanz, E., Hofer, M., Krathausen,
M., King, N., Hildago, J., Campbell, I. (2009).
Site-Specific Production of IL-6 in the Central
Nervous System Retargets and Enchances the
Inflammatory Response in Experimental
Autoimmune Encephalomyelitis. The Journal of
Immunology, 183(3), 2079-2088. <a
href="http://dx.doi.org/10.4049/jimmunol.09002
42">[More Information]</a>
2008
Sanz, E., Hofer, M., Unzeta, M., Campbell, I.
(2008). Minimal Role for STAT1 in
Interleukin-6 Signaling
and Actions in the Murine Brain. Glia, 56(2),
190-199. <a
href="http://dx.doi.org/10.1002/glia.20602">[Mo
re Information]</a>
Hofer, M., Carter, S., Muller, M., Campbell, I.
(2008). Unaltered Neurological Disease and
Mortality in CXCR3-Deficient Mice Infected
Intracranially with Lymphocytic
Choriomeningitis Virus-Armstrong. Viral
Immunology, 21(4), 425-433. <a
href="http://dx.doi.org/10.1089/vim.2008.0057"
>[More Information]</a>
2007
Muller, M., Carter, S., Hofer, M., Manders, P.,
Getts, D., Getts, M., Dreykluft, A., Lu, B.,
Gerard, C., King, N., Campbell, I. (2007).
CXCR3 Signaling Reduces the Severity of
Experimental Autoimmune Encephalomyelitis
by Controlling the Parenchymal Distribution of
Publications for Markus Hofer
Effector and Regulatory T Cells in the Central
Nervous System. The Journal of Immunology,
179(5), 2774-2786. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17709491">[More Information]</a>
Hofer, M., Mueller, M., O'Sullivan, C., Manders,
P., Campbell, I. (2007). Lethal lymphocytic
choriomeningitis virus (LCMV) infection in
STAT1 KO mice is associated with dysregulated
PD-1/B7-H1 and a phenotypic switch in the
T-cell response. International Society for
Interferon and Cytokine Research, Interferon
Anniversary Meeting (ISICR 2007), United
Kingdom: Mary Ann Liebert Inc. Publishers.
2006
Hofer, M., Schindler, A., Ehrensberger, F.,
Staeheli, P., Pagenstecher, A. (2006). Absence of
Borna disease virus in the CNS of epilepsy
patients. Journal Of Clinical Virology.
Hofer, M. (2006). Absence of Borna disease
virus in the CNS of epilepsy patients. Journal Of
Clinical Virology, 36(1), 84-85. <a
href="http://dx.doi.org/10.1016/j.jcv.2006.01.00
6">[More Information]</a>
Wacher, C., Muller, M., Hofer, M., Getts, D.,
Zabaras, R., Ousman, S., Terenzi, F., Sen, G.,
King, N., Campbell, I. (2006). Coordinated
regulation and widespread cellular expression of
the interferon-stimulated genes (ISG)-49, ISG-54
and ISG-56 in the central nervous system
following infection with distinct viruses. Journal
of Virology, 81(2), 860-871. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17079283">[More Information]</a>
2005
Hofer, M., Weber, A., Haffner, K., Berlis, A.,
Klingel, K., Kruger, M., Kandolf, R., Volk, B.
(2005). Acute hemorrhagic leukoencephalitis
(Hurst’s disease) linked to Epstein-Barr virus
infection. Acta Neuropathologica, 109(2),
226-230. <a
href="http://dx.doi.org/10.1007/s00401-004-093
0-3">[More Information]</a>
Harloff, A., Rauer, S., Hofer, M., Klisch, J., Els,
T. (2005). Fulminant acute disseminated
encephalomyelitis mimicking acute bacterial
meningoencephalitis. European Journal of
Neurology, 12(1), 67-69.
Hofer, M., Finger, C., Pagenstecher, A. (2005).
Molecular genotyping of the murine H-2K MHC
class I allele. Journal of Immunological Methods,
302(1-2), 168-171. <a
href="http://dx.doi.org/10.1016/j.jim.2005.04.00
1">[More Information]</a>
2004
Friedl, G., Hofer, M., Auber, B., Sauder, C.,
Hausmann, J., Staeheli, P., Pagenstecher, A.
(2004). Borna Disease Virus Multiplication in
Mouse Organotypic Slice Cultures Is
Site-Specifically Inhibited by Gamma Interferon
but Not by Interleukin-12. Journal of Virology,
78(3), 1212-1218.
Hofer, M., Hausmann, J., Staeheli, P.,
Pagenstecher, A. (2004). Cerebral Expression of
Interleukin-12 Induces Neurological Disease via
Differential Pathways and Recruits
Antigen-Specific T Cells in Virus-Infected Mice.
The American Journal of Pathology, 165(3),
949-958.
2002
Freude, S., Hausmann, J., Hofer, M.,
Pham-Mitchell, N., Campbell, I., Staeheli, P.,
Pagenstecher, A. (2002). Borna disease virus
accelerates inflammation and disease associated
with transgenic expression of interleukin-12 in
the central nervous system. Journal Of Clinical
Virology, 76(23), 12223-122232.
2001
Allmang, U., Hofer, M., Herzog, S., Bechter, K.,
Staeheli, P. (2001). Low avidity of human serum
antibodies for Borna disease virus antigens
questions their diagnostic value. Molecular
Psychiatry, 6(3), 329-333.
Download